Thomas R. Martin

27.0k total citations · 3 hit papers
243 papers, 19.8k citations indexed

About

Thomas R. Martin is a scholar working on Pulmonary and Respiratory Medicine, Immunology and Physiology. According to data from OpenAlex, Thomas R. Martin has authored 243 papers receiving a total of 19.8k indexed citations (citations by other indexed papers that have themselves been cited), including 119 papers in Pulmonary and Respiratory Medicine, 89 papers in Immunology and 39 papers in Physiology. Recurrent topics in Thomas R. Martin's work include Respiratory Support and Mechanisms (60 papers), Immune Response and Inflammation (58 papers) and Neonatal Respiratory Health Research (57 papers). Thomas R. Martin is often cited by papers focused on Respiratory Support and Mechanisms (60 papers), Immune Response and Inflammation (58 papers) and Neonatal Respiratory Health Research (57 papers). Thomas R. Martin collaborates with scholars based in United States, Japan and Canada. Thomas R. Martin's co-authors include Gustavo Matute‐Bello, Charles W. Frevert, Richard Maunder, Richard B. Goodman, Michael A. Matthay, Cameron P. Simmons, Jennifer R. Tisoncik, Jeremy Farrar, Michael G. Katze and Marcus J. Korth and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Thomas R. Martin

238 papers receiving 19.3k citations

Hit Papers

Into the Eye of the Cytokine Storm 1998 2026 2007 2016 2012 2008 1998 400 800 1.2k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas R. Martin United States 76 8.1k 6.7k 3.6k 3.4k 3.1k 243 19.8k
Theodore J. Standiford United States 79 4.0k 0.5× 7.2k 1.1× 4.5k 1.2× 1.5k 0.4× 4.1k 1.3× 237 17.3k
Cory M. Hogaboam United States 78 6.7k 0.8× 6.9k 1.0× 3.9k 1.1× 3.5k 1.0× 2.7k 0.9× 322 18.9k
Galen B. Toews United States 80 9.4k 1.2× 4.5k 0.7× 3.3k 0.9× 3.0k 0.9× 5.0k 1.6× 222 20.4k
Daniel G. Remick United States 84 2.9k 0.4× 9.3k 1.4× 4.9k 1.3× 2.1k 0.6× 5.7k 1.8× 335 23.5k
Wim A. Buurman Netherlands 93 3.8k 0.5× 7.2k 1.1× 6.8k 1.9× 5.1k 1.5× 5.0k 1.6× 455 28.6k
Lester Kobzik United States 71 3.5k 0.4× 5.5k 0.8× 5.1k 1.4× 4.9k 1.5× 1.9k 0.6× 264 19.1k
Guy A. Zimmerman United States 98 4.6k 0.6× 8.6k 1.3× 10.5k 2.9× 3.0k 0.9× 3.7k 1.2× 262 32.6k
David A. Schwartz United States 80 11.0k 1.4× 6.0k 0.9× 4.1k 1.1× 4.8k 1.4× 3.0k 1.0× 317 22.9k
Jack Gauldie Canada 95 9.1k 1.1× 9.1k 1.4× 8.2k 2.2× 4.1k 1.2× 3.3k 1.1× 416 31.9k
Niels Borregaard Denmark 88 2.8k 0.4× 13.4k 2.0× 10.2k 2.8× 2.9k 0.9× 2.8k 0.9× 254 30.0k

Countries citing papers authored by Thomas R. Martin

Since Specialization
Citations

This map shows the geographic impact of Thomas R. Martin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas R. Martin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas R. Martin more than expected).

Fields of papers citing papers by Thomas R. Martin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas R. Martin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas R. Martin. The network helps show where Thomas R. Martin may publish in the future.

Co-authorship network of co-authors of Thomas R. Martin

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas R. Martin. A scholar is included among the top collaborators of Thomas R. Martin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas R. Martin. Thomas R. Martin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Martin, Thomas R., Carolyn S. Calfee, Kathleen D. Liu, et al.. (2024). Anti-CD14 Treatment in Patients With Severe COVID-19 Clinical and Biological Effects in a Phase 2 Randomized Open-Label Adaptive Platform Clinical Trial. PubMed. 3(1). 100117–100117.
2.
Martin, Thomas R., Daniel Saenz, Pamela Myers, et al.. (2023). Dosimetric characterization of a new surface‐conforming electron MLC prototype. Journal of Applied Clinical Medical Physics. 25(2). e14173–e14173. 2 indexed citations
3.
Martin, Thomas R., Rachel L. Zemans, Lorraine B. Ware, et al.. (2022). New Insights into Clinical and Mechanistic Heterogeneity of the Acute Respiratory Distress Syndrome: Summary of the Aspen Lung Conference 2021. American Journal of Respiratory Cell and Molecular Biology. 67(3). 284–308. 18 indexed citations
4.
Martin, Thomas R., Mark M. Wurfel, Ivan Zanoni, & Richard J. Ulevitch. (2020). Targeting innate immunity by blocking CD14: Novel approach to control inflammation and organ dysfunction in COVID-19 illness. EBioMedicine. 57. 102836–102836. 40 indexed citations
5.
Martin, Thomas R., Garrison H. Ayars, John Butler, & Leonard C. Altman. (2015). The Comparative Toxicity of Volcanic Ash and Quartz. American Review of Respiratory Disease.
6.
Herrero, Raquel, Osamu Kajikawa, Gustavo Matute‐Bello, et al.. (2011). The biological activity of FasL in human and mouse lungs is determined by the structure of its stalk region. Journal of Clinical Investigation. 121(3). 1174–1190. 48 indexed citations
7.
Stapleton, Renee D., Thomas R. Martin, Noel S. Weiss, et al.. (2011). A phase II randomized placebo-controlled trial of omega-3 fatty acids for the treatment of acute lung injury*. Critical Care Medicine. 39(7). 1655–1662. 97 indexed citations
8.
Levy, Mitchell M., Gordon R. Bernard, Rob Fowler, et al.. (2005). Clinical Issues and Research in Respiratory Failure from Severe Acute Respiratory Syndrome. American Journal of Respiratory and Critical Care Medicine. 171(5). 518–526. 42 indexed citations
9.
Luce, John M., Richard J. Cook, Thomas R. Martin, et al.. (2004). The Ethical Conduct of Clinical Research Involving Critically Ill Patients in the United States and Canada. American Journal of Respiratory and Critical Care Medicine. 170(12). 1375–1384. 64 indexed citations
10.
Nelson, Scott M. & Thomas R. Martin. (2000). Cytokines in pulmonary disease: infection and inflammation.. M. Dekker eBooks. 15 indexed citations
11.
Kurahashi, Kiyoyasu, Osamu Kajikawa, Teiji Sawa, et al.. (1999). Pathogenesis of septic shock in Pseudomonas aeruginosa pneumonia. Journal of Clinical Investigation. 104(6). 743–750. 242 indexed citations
12.
Brewer, Joanne P., et al.. (1999). Genetic Variability in Pulmonary Physiological, Cellular, and Antibody Responses to Antigen in Mice. American Journal of Respiratory and Critical Care Medicine. 160(4). 1150–1156. 119 indexed citations
13.
Martin, Thomas R., Gordon D. Rubenfeld, Richard B. Goodman, et al.. (1997). Relationship Between Soluble CD14, Lipopolysaccharide Binding Protein, and the Alveolar Inflammatory Response in Patients With Acute Respiratory Distress Syndrome. American Journal of Respiratory and Critical Care Medicine. 155(3). 937–944. 134 indexed citations
14.
Pittet, Jean‐François, Robert C. Mackersie, Thomas R. Martin, & Michael A. Matthay. (1997). Biological Markers of Acute Lung Injury: Prognostic and Pathogenetic Significance. American Journal of Respiratory and Critical Care Medicine. 155(4). 1187–1205. 436 indexed citations
15.
Hopkins, Susan R., R. B. Schoene, William R. Henderson, et al.. (1997). Intense Exercise Impairs the Integrity of the Pulmonary Blood-Gas Barrier in Elite Athletes. American Journal of Respiratory and Critical Care Medicine. 155(3). 1090–1094. 185 indexed citations
16.
Kajikawa, Osamu, Ellen Caldwell, M. Johnson, et al.. (1997). Pulmonary and Systemic Inflammatory Responses in Rabbits With Gram-Negative Pneumonia. American Journal of Respiratory and Critical Care Medicine. 155(6). 2030–2040. 46 indexed citations
17.
Goodman, Richard B., Robert M. Strieter, Diane P. Martin, et al.. (1996). Inflammatory Cytokines in Patients With Persistence of the Acute Respiratory Distress Syndrome. American Journal of Respiratory and Critical Care Medicine. 154(3). 602–611. 435 indexed citations
18.
Steinberg, K P, John Milberg, Thomas R. Martin, et al.. (1994). Evolution of Bronchoalveolar Cell Populations in the Adult Respiratory Distress Syndrome. American Journal of Respiratory and Critical Care Medicine. 150(1). 113–122. 316 indexed citations
19.
Wong, G, Nevio Cimolai, James E. Dimmick, & Thomas R. Martin. (1992). Pastewella multocida chorioamnionitis from vaginal transmission. Acta Obstetricia Et Gynecologica Scandinavica. 71(5). 384–387. 13 indexed citations
20.
Idell, Steven, E G Levin, Bradford S. Schwartz, et al.. (1989). Local abnormalities in coagulation and fibrinolytic pathways predispose to alveolar fibrin deposition in the adult respiratory distress syndrome.. Journal of Clinical Investigation. 84(2). 695–705. 265 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026